Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant.
作者信息
Marcoux Curtis, Pasyar Sarah, Milton Denái R, Khan Hina N, Tanner Mark R, Bashir Qaiser, Srour Samer, Saini Neeraj, Lin Paul, Ramdial Jeremy, Nieto Yago, Neupane Niraj, Lee Hans C, Patel Krina K, Tang Guilin, Aljawai Yosra, Kebriaei Partow, Thomas Sheeba K, Orlowski Robert Z, Shpall Elizabeth J, Champlin Richard, Qazilbash Muzaffar H, Pasvolsky Oren
机构信息
Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
出版信息
Br J Haematol. 2025 Feb;206(2):763-765. doi: 10.1111/bjh.19937. Epub 2024 Nov 28.
Abstract
摘要
相似文献
1
Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant.体重指数对接受一线自体干细胞移植的多发性骨髓瘤患者预后的影响。
Br J Haematol. 2025 Feb;206(2):763-765. doi: 10.1111/bjh.19937. Epub 2024 Nov 28.
2
Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).年轻供者年龄和 upfront tandem 是接受 tandem 自体-异基因干细胞移植治疗的多发性骨髓瘤患者生存的两个独立预后因素：来自法国骨髓和细胞治疗协会（SFGM-TC）的回顾性研究。
Haematologica. 2012 Apr;97(4):482-90. doi: 10.3324/haematol.2011.049742. Epub 2011 Nov 4.
3
Role of Autologous Transplant in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Triplets: A Systematic Review and Meta-Analysis.自体移植在接受新型三联疗法治疗的新诊断多发性骨髓瘤患者中的作用：一项系统评价和荟萃分析。
Acta Haematol. 2024 Sep 16:1-9. doi: 10.1159/000540232.
4
Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience.高危多发性骨髓瘤患者 upfront 串联自体非清髓异基因造血干细胞移植：一项长期单中心经验。
Intern Med J. 2022 Jul;52(7):1263-1267. doi: 10.1111/imj.15842. Epub 2022 Jul 9.
5
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades.三十年来多发性骨髓瘤一线自体移植后结局的变化趋势。
Transplant Cell Ther. 2024 Aug;30(8):772.e1-772.e11. doi: 10.1016/j.jtct.2024.06.001. Epub 2024 Jun 7.
6
Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.与多发性骨髓瘤自体干细胞移植结果相关的临床因素：采用MEL200进行前期移植仍是治疗标准。
Ann Hematol. 2024 Jan;103(1):269-283. doi: 10.1007/s00277-023-05511-z. Epub 2023 Oct 25.
7
Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation.接受早期自体造血干细胞移植的标准风险多发性骨髓瘤患者的预后
Transplant Cell Ther. 2025 Mar;31(3):166.e1-166.e9. doi: 10.1016/j.jtct.2024.12.023. Epub 2024 Dec 31.
8
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation.诱导治疗采用 VRD 方案与 VCD 方案对接受 upfront 自体造血干细胞移植的部分缓解或更好疗效的多发性骨髓瘤患者结局的影响。
Transplant Cell Ther. 2022 Feb;28(2):83.e1-83.e9. doi: 10.1016/j.jtct.2021.10.022. Epub 2021 Nov 12.
9
Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17p.新诊断的伴有17p缺失的多发性骨髓瘤患者接受一线自体造血干细胞移植的真实世界结果
Transplant Cell Ther. 2025 Jan;31(1):12.e1-12.e10. doi: 10.1016/j.jtct.2024.10.011. Epub 2024 Oct 22.
10
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity-score matched analysis.接受一线自体干细胞移植的黑人多发性骨髓瘤患者与白人患者的生存结果相似：一项倾向评分匹配分析。
Am J Hematol. 2021 Dec 1;96(12):E455-E457. doi: 10.1002/ajh.26360. Epub 2021 Oct 4.
引用本文的文献
1
Unraveling Obesity and Multiple Myeloma: Insights from Epidemiology and Molecular Mechanisms.揭开肥胖与多发性骨髓瘤之谜：来自流行病学和分子机制的见解
Curr Obes Rep. 2025 Jun 5;14(1):52. doi: 10.1007/s13679-025-00644-w.
本文引用的文献
1
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial.内脏肥胖对多发性骨髓瘤患者临床结局和生活质量的影响：STaMINA（BMT CTN 0702）试验的二次数据分析。
Transplant Cell Ther. 2024 Jul;30(7):698.e1-698.e10. doi: 10.1016/j.jtct.2024.01.053. Epub 2024 Jan 19.
2
Extreme body mass index and survival in newly diagnosed multiple myeloma patients.极端体重指数与新诊断的多发性骨髓瘤患者的生存率
Blood Cancer J. 2023 Jan 12;13(1):13. doi: 10.1038/s41408-022-00782-7.
3
Body Fatness and Cancer--Viewpoint of the IARC Working Group.身体肥胖与癌症——国际癌症研究机构工作组的观点
N Engl J Med. 2016 Aug 25;375(8):794-8. doi: 10.1056/NEJMsr1606602.
4
Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.体型与多发性骨髓瘤死亡率：20项前瞻性研究的汇总分析
Br J Haematol. 2014 Sep;166(5):667-76. doi: 10.1111/bjh.12935. Epub 2014 May 23.
5
Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.造血细胞移植合并症指数可预测多发性骨髓瘤患者自体造血细胞移植后的生存情况。
Biol Blood Marrow Transplant. 2014 Mar;20(3):402-408.e1. doi: 10.1016/j.bbmt.2013.12.557. Epub 2013 Dec 14.
6
Influence of body mass index on survival in veterans with multiple myeloma.体重指数对多发性骨髓瘤退伍军人生存的影响。
Oncologist. 2013;18(10):1074-9. doi: 10.1634/theoncologist.2013-0015. Epub 2013 Sep 18.
7
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.肥胖对多发性骨髓瘤自体造血干细胞移植后结局的影响。
Biol Blood Marrow Transplant. 2011 Dec;17(12):1765-74. doi: 10.1016/j.bbmt.2011.05.005. Epub 2011 May 11.
Zotero 插件